Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Phase II explorative trial to prospectively investigate predictive molecular biomarkers for efficacy of panitumumab (P) in platinum-pretreated head and neck squamous cell cancer (HNSCC)
Siano M (2015). Phase II explorative trial to prospectively investigate predictive molecular biomarkers for efficacy of panitumumab (P) in platinum-pretreated head and neck squamous cell cancer (HNSCC).
29.09.2015Phase II explorative trial to prospectively investigate predictive molecular biomarkers for efficacy of panitumumab (P) in platinum-pretreated head and neck squamous cell cancer (HNSCC)
29.09.2015ESMO 2015
Siano Marco
Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): a retrospective analysis
Siano M, Resteghini c, Licitra L, Bossi P (2015). Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): a retrospective analysis.
29.09.2015Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): a retrospective analysis
29.09.2015ESMO 2015
Siano Marco, Resteghini c, Licitra L, Bossi P
Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC)
Siano M (2015). Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC).
28.09.2015Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC)
28.09.2015ESMO 2015
Siano Marco
Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis
Ebinger S, Warschkow R, Tarantino I, Schmied B, Gueller U, Schiesser M. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis. Gastric Cancer 2015
21.09.2015Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis
21.09.2015Gastric Cancer 2015
Ebinger Sabrina M, Warschkow Rene, Tarantino Ignazio, Schmied Bruno, Gueller Ulrich, Schiesser Marc
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
Munzone E, Colleoni M, Goldhirsch A, Coates A, Gelber R, Price K, Lelkaitis G, Bibeau F, Macgrogan G, Ejlertsen B, Thürlimann B, Viale G, Mallon E, Gusterson B, Giobbie-Hurder A, International Breast Cancer Study Group and the BIG 1-98 Collaborative Group. Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial. Ann Oncol 2015
19.09.2015Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
19.09.2015Ann Oncol 2015
Munzone E, Colleoni M, Goldhirsch A, Coates A S, Gelber R D, Price K N, Lelkaitis G, Bibeau F, Macgrogan G, Ejlertsen B, Thürlimann Beat, Viale G, Mallon E, Gusterson B A, Giobbie-Hurder A, International Breast Cancer Study Group and the BIG 1-98 Collaborative Group
Tongue myokymia as an unusual symptom of a meningioma of the craniospinal junction
Leupold D, Kim O, Brugnolaro C, Hundsberger T (2015). Tongue myokymia as an unusual symptom of a meningioma of the craniospinal junction. Präsentiert bei: 7th Swiss neuro-oncology meeting, Rorschach
18.09.2015Tongue myokymia as an unusual symptom of a meningioma of the craniospinal junction
18.09.20157th Swiss neuro-oncology meeting
Leupold Daniela, Kim O.C., Brugnolaro Ch., Hundsberger Thomas
The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial
Widschwendter P, Jueckstock J, Neugebauer J, Trapp E, Fasching P, Beckmann M, Schneeweiss A, Schrader I, Rack B, Janni W, Andergassen U, Kost B, Friedl T, Schwentner L, DeGregorio N, Jaeger B, Schramm A, Bekes I, Deniz M, Lato K, Weissenbacher T, Scholz C. The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial. Breast Cancer Res 2015; 17:129.
18.09.2015The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial
18.09.2015Breast Cancer Res 2015; 17:129
Widschwendter Peter, Jueckstock Julia, Neugebauer Julia, Trapp Elisabeth, Fasching Peter A, Beckmann Matthias W, Schneeweiss Andreas, Schrader Ines, Rack Brigitte, Janni Wolfgang, Andergassen Ulrich, Kost Bernd, Friedl Thomas Wp, Schwentner Lukas, DeGregorio Nikolaus, Jaeger Bernadette, Schramm Amelie, Bekes Inga, Deniz Miriam, Lato Krisztian, Weissenbacher Tobias, Scholz Christoph
Schweizerisch-österreichische Neuroonkologie-Tagung
Hundsberger T (2015). Schweizerisch-österreichische Neuroonkologie-Tagung - Erfahrungsaustausch unter Kollegen.
17.09.2015Schweizerisch-österreichische Neuroonkologie-Tagung
17.09.2015Swiss-NO
Hundsberger Thomas
Minimal sample requirement for highly multiplexed protein quantification in cell lines and tissues by PCT-SWATH mass spectrometry
Shao S, Guo T, Koh C, Gillessen Sommer S, Jörger M, Jochum W, Aebersold R. Minimal sample requirement for highly multiplexed protein quantification in cell lines and tissues by PCT-SWATH mass spectrometry. Proteomics 2015; 15:3711-21.
10.09.2015Minimal sample requirement for highly multiplexed protein quantification in cell lines and tissues by PCT-SWATH mass spectrometry
10.09.2015Proteomics 2015; 15:3711-21
Shao Shiying, Guo Tiannan, Koh Chiek Ching, Gillessen Sommer Silke, Jörger Markus, Jochum Wolfram, Aebersold Ruedi
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program
Schramm A, Janni W, Wallwiener D, Taran F, Hartkopf A, Meier-Stiegen F, Pantel K, Schneeweiss A, Müller V, Alunni-Fabbroni M, Trapp E, Rack B, Huober J, De Gregorio N, Scholz C, Schochter F, Friedl T, Fehm T. Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program. Arch Gynecol Obstet 2015; 293:271-81.
09.09.2015Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program
09.09.2015Arch Gynecol Obstet 2015; 293:271-81
Schramm Amelie, Janni Wolfgang, Wallwiener Diethelm, Taran Florin-Andrei, Hartkopf Andreas, Meier-Stiegen Franziska, Pantel Klaus, Schneeweiss Andreas, Müller Volkmar, Alunni-Fabbroni Marianna, Trapp Elisabeth, Rack Brigitte, Huober Jens, De Gregorio Nikolaus, Scholz Christoph, Schochter Fabienne, Friedl Thomas W P, Fehm Tanja
Reply to the letter to the editor 'Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al
Gillessen Sommer S, Fanti S, Omlin A, panelists and authors of APCCC. Reply to the letter to the editor 'Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al. Ann Oncol 2015; 26:2354-5.
07.09.2015Reply to the letter to the editor 'Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al
07.09.2015Ann Oncol 2015; 26:2354-5
Gillessen Sommer Silke, Fanti S, Omlin Aurelius, panelists and authors of APCCC
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
Feilchenfeldt J, Jochum W, Shoji H, Kushima R, Wagner D, Shimada Y, Cats A, Knuth A, Moch H, Aebi S, Diebold J, Khanfir K, Varga Z, Siano M, Grabsch H, Held U, Schuknecht B, Trip A, Hamaguchi T, Gut P, Balague O, Hofer S. Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). Br J Cancer 2015; 113:716-21.
27.08.2015Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
27.08.2015Br J Cancer 2015; 113:716-21
Feilchenfeldt J, Jochum Wolfram, Shoji H, Kushima R, Wagner D, Shimada Y, Cats A, Knuth A, Moch H, Aebi S, Diebold J, Khanfir K, Varga Z, Siano Marco, Grabsch H I, Held U, Schuknecht B, Trip A, Hamaguchi T, Gut P, Balague O, Hofer S
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
Pless M, Bijelovic M, Ochsenbein A, Meier U, Mamot C, Rauch D, Gautschi O, Betticher D, Mirimanoff R, Peters S, Roth A, Zippelius A, Stupp R, Ris H, Stahel R, Weder W, Thierstein S, Gerard M, Xyrafas A, Früh M, Cathomas R. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet 2015; 386:1049-56.
11.08.2015Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
11.08.2015Lancet 2015; 386:1049-56
Pless Miklos, Bijelovic Milorad, Ochsenbein Adrian, Meier Urs R, Mamot Christoph, Rauch Daniel, Gautschi Oliver, Betticher Daniel C, Mirimanoff René-Olivier, Peters Solange, Roth Arnaud, Zippelius Alfred, Stupp Roger, Ris Hans-Beat, Stahel Rolf A, Weder Walter, Thierstein Sandra, Gerard Marie-Aline, Xyrafas Alexandros, Früh Martin, Cathomas Richard
Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment
Hitz F, Villa D, Shenkier T, Sehn L, Savage K, Moccia A, Hoskins P, Gascoyne R, Connors J, Klasa R. Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment. Ann Hematol 2015; 94:1839-43.
07.08.2015Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment
07.08.2015Ann Hematol 2015; 94:1839-43
Hitz Felicitas, Villa D, Shenkier T, Sehn L H, Savage K J, Moccia A, Hoskins P, Gascoyne R D, Connors J M, Klasa R
Effect of telemetric monitoring in the first 30 days of continuous positive airway pressure adaptation for obstructive sleep apnoea syndrome - a controlled pilot study
Frasnelli M, Baty F, Niedermann J, Brutsche M, Schoch O. Effect of telemetric monitoring in the first 30 days of continuous positive airway pressure adaptation for obstructive sleep apnoea syndrome - a controlled pilot study. J Telemed Telecare 2015; 22:209-14.
06.08.2015Effect of telemetric monitoring in the first 30 days of continuous positive airway pressure adaptation for obstructive sleep apnoea syndrome - a controlled pilot study
06.08.2015J Telemed Telecare 2015; 22:209-14
Frasnelli Matthias, Baty Florent, Niedermann Jolanda, Brutsche Martin, Schoch Otto
Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes
Rothermundt C, Sternberg C, Schmidinger M, Rini B, Porta C, Oldenburg J, McDermott D, Larkin J, Grünwald V, Gillessen Sommer S, Escudier B, Eisen T, Cerbone L, Bailey A, Putora P. Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes. Oncologist 2015; 20:1028-35.
03.08.2015Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes
03.08.2015Oncologist 2015; 20:1028-35
Rothermundt Christian, Sternberg Cora, Schmidinger Manuela, Rini Brian, Porta Camillo, Oldenburg Jan, McDermott David, Larkin James, Grünwald Viktor, Gillessen Sommer Silke, Escudier Bernard, Eisen Tim, Cerbone Linda, Bailey Alexandra, Putora Paul Martin
Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor
Gueller U, Tarantino I, Cerny T, Schmied B, Warschkow R. Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor. BMC cancer 2015; 15:557.
30.07.2015Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor
30.07.2015BMC cancer 2015; 15:557
Gueller Ulrich, Tarantino Ignazio, Cerny Thomas, Schmied Bruno, Warschkow Rene
Assessment of Anticancer-Treatment Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer - Going beyond PSA and Imaging, a Systematic Literature Review
Schmid S, Omlin A, Blum D, Strasser F, Gillessen Sommer S, Rothermundt C. Assessment of Anticancer-Treatment Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer - Going beyond PSA and Imaging, a Systematic Literature Review. Ann Oncol 2015
27.07.2015Assessment of Anticancer-Treatment Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer - Going beyond PSA and Imaging, a Systematic Literature Review
27.07.2015Ann Oncol 2015
Schmid Sabine, Omlin Aurelius, Blum D, Strasser Florian, Gillessen Sommer Silke, Rothermundt Christian
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial
Metzger Filho O, Coates A, Regan M, Price K, Debled M, Ejlertsen B, Colleoni M, Gelber R, Thürlimann B, Winer E, Viale G, Gusterson B, Mallon E, Giobbie-Hurder A, Goldhirsch A. Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial. J Clin Oncol 2015; 33:2772-9.
27.07.2015Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial
27.07.2015J Clin Oncol 2015; 33:2772-9
Metzger Filho Otto, Coates Alan S, Regan Meredith M, Price Karen N, Debled Marc, Ejlertsen Bent, Colleoni Marco, Gelber Richard D, Thürlimann Beat, Winer Eric P, Viale Giuseppe, Gusterson Barry, Mallon Elizabeth, Giobbie-Hurder Anita, Goldhirsch Aron
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Kaufmann M, Kilburn L, Perrone F, Rea D, Thürlimann B, van de Velde C, Pan H, Peto R, Davies C, Gnant M, Dubsky P, Cuzick J, Dowsett M, Forbes J, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes R, Gray R. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 2015; 386:1341-52.
23.07.2015Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
23.07.2015Lancet 2015; 386:1341-52
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Kaufmann M, Kilburn L, Perrone F, Rea D, Thürlimann Beat, van de Velde C, Pan H, Peto R, Davies C, Gnant M, Dubsky P, Cuzick J, Dowsett M, Forbes J F, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes R C, Gray R